Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Rupert Bauersachs"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 4, Pp 532-549 (2020)
Abstract Cancer‐associated venous thromboembolism (VTE) is a frequent, potentially life‐threatening event that complicates cancer management. Anticoagulants are the cornerstone of therapy for the treatment and prevention of cancer‐associated th
Externí odkaz:
https://doaj.org/article/3660c3334ebf4d9d85337c74edd219e0
Autor:
Maria Cristina Vedovati, Michela Giustozzi, Andrés Munoz, Laurent Bertoletti, Alexander T. Cohen, Frederikus A. Klok, Jean M. Connors, Rupert Bauersachs, Benjamin Brenner, Mauro Campanini, Cecilia Becattini, Giancarlo Agnelli
Publikováno v:
European Journal of Internal Medicine. 112:29-36
Autor:
Cecilia Becattini, Giancarlo Agnelli, Melina Verso, Rupert Bauersachs, Menno V. Huisman, Andrés Muñoz, Mario Mandalà, Giorgio Vescovo
Publikováno v:
European Journal of Cancer, 148, 371-381. ELSEVIER SCI LTD
Background: Whether concomitant administration of anticancer agents influences the efficacy and safety of oral anticoagulants in patients treated for cancer-associated venous thromboembolism (VTE) is undefined. The pharmacological interaction between
Autor:
Rupert Bauersachs, Walter Ageno, Gualberto Gussoni, Ander Cohen, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Menno V. Huisman
Publikováno v:
Thrombosis and Haemostasis
Thrombosis and Haemostasis. GEORG THIEME VERLAG KG
Thrombosis and Haemostasis. GEORG THIEME VERLAG KG
Background Direct oral anticoagulants are recommended for the treatment of cancer-associated thrombosis (CAT) as an alternative to low-molecular-weight heparin (LMWH), but an increased bleeding risk in patients with gastrointestinal cancer was report
Autor:
Antonio Sanchez, Cecilia Becattini, Giancarlo Agnelli, Dario Manfellotto, Alexander T. Cohen, Laurent Bertoletti, Jean M. Connors, Benjamin Brenner, Rupert Bauersachs, Giorgio Maraziti
The effect of renal impairment (RI) on risk of bleeding and recurrent thrombosis in cancer patients treated with direct oral anticoagulants for venous thromboembolism (VTE) is undefined. We ran a prespecified analysis of the randomized Caravaggio stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4c133a6e7734f10f05cbbf5933b7cd
https://hdl.handle.net/11391/1508707
https://hdl.handle.net/11391/1508707
Autor:
Ajay K. Kakkar, Rodney Hughes, Mark Levine, Anna Falanga, Rupert Bauersachs, Alex Kahney, John Wong, Gloria Kayani
Publikováno v:
The Oncologist
Background Fundamental Research in Oncology and Thrombosis (FRONTLINE) is a global survey of physicians' perceptions and practice in the management of venous thromboembolism (VTE) in patients with cancer. Materials and Methods The present survey, FRO
Autor:
Cecilia Becattini, Benjamin Brenner, Giancarlo Agnelli, Maria Rosales Suero, Andrés Muñoz, Adam Torbicki, Gualberto Gussoni, Isabelle Mahé, Laura Franco, Rupert Bauersachs, Jean M. Connors, Eva N. Hamulyak, Catherine Lambert
Publikováno v:
Thrombosis and haemostasis, Vol. 122, no.5, p. 796-807 (2022)
Thrombosis and haemostasis. Schattauer GmbH
Thrombosis and haemostasis. Schattauer GmbH
Efficacy and safety of anticoagulant treatment for venous thromboembolism (VTE) may vary in patients with different cancer sites. We evaluated the rates of VTE recurrence and major bleeding and the relative efficacy and safety of 6-month treatment wi
Autor:
Rupert Bauersachs, PD Gumbs, Giancarlo Agnelli, Ling-Hsiang Chuang, Alexander T. Cohen, David Jiménez, Anselm K. Gitt, Patrick Mismetti, Ben van Hout, S Kroep, Stephen N Willich, Manuel Monreal
Publikováno v:
Quality of Life Research
Purpose Little is known about the quality of life following pulmonary embolism (PE). The aim of the study was to assess the 12-month illness burden in terms of health-related quality of life (HrQoL) and mortality, in relation to differences in patien
Publikováno v:
Critical Reviews in Oncology/Hematology. 132:169-179
Patients with cancer are at high risk of developing venous thromboembolism (VTE). Although the recommended low molecular weight heparins (LMWHs) are more effective than vitamin K antagonists in treating VTE in patients with cancer, they have limitati
Autor:
Menno V. Huisman, Giancarlo Agnelli, Cecilia Becattini, Alexander T. Cohen, Francesco Dentali, Jean M. Connors, Ana Belen Ruperez Blanco, Nicolas Falvo, Michela Giustozzi, Sebastian Szmit, Rupert Bauersachs
Publikováno v:
Journal of Thrombosis and Haemostasis, 19(11), 2751-2759. WILEY
Background Clinical guidelines advise similar anticoagulant treatment for symptomatic and incidental cancer-associated venous thromboembolism (VTE). We investigated clinical features and outcomes of cancer patients with incidental or symptomatic VTE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::235c324b59acb20d5f9828356d9b8f67
http://hdl.handle.net/11383/2123920
http://hdl.handle.net/11383/2123920